You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

DrugPatentWatch Database Updates: New Patent Additions

✉ Email this page to a colleague

« Back to Dashboard

DrugPatentWatch Database Updates: New Patent Additions

These are patents which have been reported by the FDA since the last major update; they are not yet in the main database.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Number	Approval Date	Type	RLD	Patent No.	Product	Substance	Delist Requested	Patent Expiration	Date Submitted	Usecode	Patented / Exclusive Use
Vertical Pharms	DSUVIA	sufentanil citrate	TABLET	209128	001	Nov 2, 2018	DISCN	Yes	12,033,733	Y			⤷ Get Started Free	2024-07-31
Amarin Pharms	VASCEPA	icosapent ethyl	CAPSULE	202057	001	Jul 26, 2012	RX	Yes	8,357,677				⤷ Get Started Free	2017-06-26	U-1287	METHOD OF REDUCING TG LEVELS IN PATIENT SUFFERING FROM SEVERE HYPERTRIGLYCERIDEMIA
Amarin Pharms	VASCEPA	icosapent ethyl	CAPSULE	202057	002	Feb 16, 2017	RX	Yes	8,357,677				⤷ Get Started Free	2017-06-26	U-1287	METHOD OF REDUCING TG LEVELS IN PATIENT SUFFERING FROM SEVERE HYPERTRIGLYCERIDEMIA
Melinta	BAXDELA	delafloxacin meglumine	POWDER	208611	001	Jun 19, 2017	RX	Yes	12,036,219				⤷ Get Started Free	2024-07-30	U-3967	TREATING AN ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION (ABSSSI) IN AN OVERWEIGHT OR OBESE PATIENT BY INTRAVENOUSLY (IV) ADMINISTERING 300MG OF DELAFLOXACIN OR A PHARMACEUTICALLY ACCEPTABLE SALT, TWICE A DAY
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Number	>Approval Date	>Type	>RLD	>Patent No.	>Product	>Substance	>Delist Requested	>Patent Expiration	>Date Submitted	>Usecode	>Patented / Exclusive Use

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.